Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Option Care Health, Inc.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Option Care Health (OPCH), Teva Pharmaceutical (TEVA...

Analysts Are Bullish on These Healthcare Stocks: Option Care Health (OPCH), Teva Pharmaceutical (TEVA)

In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Option Care Health, with a price target of $30.00. S...

Truist Financial Reaffirms Their Buy Rating on Option Care Health (OPCH)

In a report released yesterday, Joanna Gajuk from Bank of America Securities reiterated a Hold rating on Option Care Health, with a price target of...

Bank of America Securities Keeps Their Hold Rating on Option Care Health (OPCH)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Option Care Health (OPCH) and Ionis Pharmaceuticals ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	OPCH	$23.95	0.00%	1.89M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	OPCH	$23.95	0%	1.89M
3
4
5
6

OPCH

Get Option Care Health, Inc. Data in Excel

Get Option Care Health, Inc. Data in Excel